OLD Point Trust & Financial Services N A decreased its stake in shares of Baxter International Inc (NYSE:BAX) by 4.0% during the third quarter, HoldingsChannel reports. The firm owned 33,282 shares of the medical instruments supplier’s stock after selling 1,375 shares during the quarter. OLD Point Trust & Financial Services N A’s holdings in Baxter International were worth $2,565,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in BAX. Bridgeworth LLC bought a new stake in shares of Baxter International during the 2nd quarter valued at about $102,000. Migdal Insurance & Financial Holdings Ltd. boosted its stake in shares of Baxter International by 3,088.9% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,435 shares of the medical instruments supplier’s stock valued at $106,000 after purchasing an additional 1,390 shares in the last quarter. Baker Ellis Asset Management LLC bought a new stake in shares of Baxter International during the 2nd quarter valued at about $111,000. Centaurus Financial Inc. bought a new stake in shares of Baxter International during the 2nd quarter valued at about $117,000. Finally, Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Baxter International by 84.4% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,748 shares of the medical instruments supplier’s stock valued at $126,000 after purchasing an additional 800 shares in the last quarter. 82.28% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NYSE BAX opened at $62.50 on Tuesday. Baxter International Inc has a 1 year low of $61.05 and a 1 year high of $78.38. The stock has a market cap of $33.22 billion, a P/E ratio of 25.20, a price-to-earnings-growth ratio of 1.67 and a beta of 1.02. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.62 and a quick ratio of 2.00.
Baxter International (NYSE:BAX) last issued its quarterly earnings results on Wednesday, October 31st. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.74 by $0.06. Baxter International had a net margin of 10.90% and a return on equity of 17.72%. The company had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.79 billion. During the same period last year, the company posted $0.64 EPS. Baxter International’s revenue was up 2.2% on a year-over-year basis. As a group, research analysts forecast that Baxter International Inc will post 2.99 earnings per share for the current fiscal year.
BAX has been the topic of a number of research reports. Zacks Investment Research raised shares of Baxter International from a “hold” rating to a “buy” rating and set a $87.00 target price on the stock in a research note on Tuesday, September 25th. Argus reissued a “hold” rating on shares of Baxter International in a research report on Tuesday, September 4th. Barclays began coverage on shares of Baxter International in a research report on Monday, October 15th. They set an “underweight” rating and a $73.00 price target for the company. Morgan Stanley lifted their price target on shares of Baxter International from $68.00 to $75.00 and gave the company an “underweight” rating in a research report on Thursday, October 11th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Baxter International from $80.00 to $85.00 and gave the company an “overweight” rating in a research report on Friday, July 27th. Two analysts have rated the stock with a sell rating, four have given a hold rating and eleven have issued a buy rating to the company’s stock. Baxter International currently has a consensus rating of “Buy” and a consensus price target of $75.63.
In other Baxter International news, SVP Giuseppe Accogli sold 17,647 shares of Baxter International stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $77.27, for a total value of $1,363,583.69. Following the completion of the transaction, the senior vice president now directly owns 59,452 shares of the company’s stock, valued at $4,593,856.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Carole J. Shapazian sold 5,400 shares of Baxter International stock in a transaction dated Wednesday, August 8th. The stock was sold at an average price of $72.97, for a total transaction of $394,038.00. Following the completion of the transaction, the director now directly owns 15,248 shares of the company’s stock, valued at $1,112,646.56. The disclosure for this sale can be found here. 0.07% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION WARNING: “OLD Point Trust & Financial Services N A Cuts Stake in Baxter International Inc (BAX)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/11/06/old-point-trust-financial-services-n-a-cuts-stake-in-baxter-international-inc-bax.html.
About Baxter International
Baxter International Inc provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.
Read More: What does the Dow Jones Industrial Average (DJIA) measure?
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.